home / stock / hoth / hoth quote
Last: | $ |
---|---|
Change Percent: | -0.21% |
Open: | $6.36 |
Close: | $4.9494 |
High: | $7.20 |
Low: | $4.51 |
Volume: | 1,039,797 |
Last Trade Date Time: | 02/12/2020 04:40:19 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $6.36 | $4.9494 | $7.20 | $4.51 | 1,039,797 | 02-12-2020 |
$ | $4.91 | $4.96 | $5.1099 | $4.8354 | 23,634 | 02-11-2020 |
$ | $4.71 | $4.88 | $5.01 | $4.71 | 15,406 | 02-10-2020 |
$ | $4.71 | $4.8731 | $4.9754 | $4.71 | 27,589 | 02-07-2020 |
$ | $4.70 | $4.78 | $5.09 | $4.63 | 81,180 | 02-06-2020 |
$ | $4.61 | $4.71 | $4.8899 | $4.51 | 53,661 | 02-05-2020 |
$ | $4.27 | $4.65 | $4.65 | $3.75 | 55,285 | 02-04-2020 |
$ | $4.60 | $4.12 | $4.69 | $4.00 | 47,471 | 02-03-2020 |
$ | $4.76 | $4.70 | $4.899 | $4.70 | 22,688 | 01-31-2020 |
$ | $4.71 | $4.6985 | $4.8154 | $4.69 | 8,020 | 01-30-2020 |
$ | $5.25 | $4.872 | $5.25 | $4.66 | 43,357 | 01-29-2020 |
$ | $4.73 | $4.955 | $5.03 | $4.73 | 30,184 | 01-28-2020 |
$ | $4.81 | $4.71 | $5.05 | $4.7055 | 18,029 | 01-27-2020 |
$ | $4.90 | $4.86 | $4.9928 | $4.8597 | 14,162 | 01-24-2020 |
$ | $5.06 | $4.91 | $5.12 | $4.91 | 15,718 | 01-23-2020 |
$ | $5.15 | $5.0601 | $5.30 | $5.031 | 37,640 | 01-22-2020 |
$ | $5.15 | $5.15 | $5.22 | $5.00 | 55,381 | 01-21-2020 |
$ | $5.26 | $5.0141 | $5.26 | $4.76 | 33,934 | 01-20-2020 |
$ | $5.26 | $5.0141 | $5.26 | $4.76 | 33,934 | 01-17-2020 |
$ | $5.36 | $5.155 | $5.3999 | $5.03 | 33,704 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Hoth Therapeutics Inc. Company Name:
HOTH Stock Symbol:
NYSE Market:
China Resources Beer (Holdings) Company Limited ADR (CRHKY) is expected to report for Q4 2023 Melco International Development Ltd. (MDEVF) is expected to report for quarter end 2023-12-31 Meridian Mining UK Societas (MRRDF) is expected to report $0 for Q4 2023 BKF Capital Group Inc (B...
Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds PR Newswire NEW YORK , March 27, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, today announced the entry into a defin...
Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment PR Newswire Merveille.ai Files Patent for Obesity Treatment, Begins Preparatory Steps for Clinical Trials, Joins Nvidia Developer Program NEW YORK , Ma...